BackKaleido Biosciences Overview

Kaleido Biosciences Receivables

Track Kaleido Biosciences's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average

Loading

Kaleido Biosciences Receivables History

Loading

Kaleido Biosciences vs. peers: Receivables Comparison

Loading

Kaleido Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Kaleido Biosciences (KLDO) FAQ

Kaleido Biosciences (KLDO) currently reports a receivables of $0 as of September 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Kaleido Biosciences's receivables history and peer comparisons.

Kaleido Biosciences's receivables changed from $0 to $0 (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kaleido Biosciences reported $0 in receivables as of September 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kaleido Biosciences, and consider following KLDO for alerts when major investors trade the stock.

Kaleido Biosciences is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KLDO with unrelated industries.